Pharmafile Logo
Pharmafocus logo
Advanced Search

Teva

Showing 15 posts of 234 posts found.

Teva’s Irvine facility gets FDA green light

May 3, 2011
Manufacturing and Production FDA, Teva, manufacturing compliance

Teva Pharmaceutical Industries has said that an injectables facility in the USA, shut down last April after quality control problems, …

News

Pharma manufacturing news in brief

April 26, 2011
Manufacturing and Production Archer Daniels Midland, Dow Chemical, IPEC Americas, Pharmatek Laboratories, Taro, Taro Pharmaceutical Industries, Teva, Teva Pharmaceutical Industries, manufacturing, manufacturing news in brief, pharma manufacturing news

Includes a formulation problem for Teva, facility updates from Taro and ADM, and a new excipient screening initiative at the …

News

Teva surges ahead

February 9, 2011
Sales and Marketing 2010 pharma results, Copaxone, Teva, Teva Pharmaceutical

Generics giant Teva enjoyed a strong year of growth in 2010, lifted by the acquisition of Ratiopharm, patent expiries of …

News

Teva plant in Israel cited by FDA, expands in Americas

February 8, 2011
Manufacturing and Production Corporacion Infarmasa, FDA, Peru, Teva, Teva Pharmaceutical, generics, generics manufacturing, manufacturing compliance

A manufacturing facility in Jerusalem operated by Teva Pharmaceutical failed to pass muster in an FDA inspection, prompting a warning …

News

Novartis challenges Roche with MabThera biosimilar

January 11, 2011
Research and Development Lonza MabThera, Novartis, Roche, Teva, biosimilar, rituximab

Novartis’ generics unit Sandoz has begun mid-stage trials of a biosimilar version of Roche’s blockbuster drug MabThera. The phase II …

News
Nycomed COPD iPhone app

Digital Pharma: Pharma iPhone app update

October 15, 2010
Medical Communications Astellas, Boehringer, Digital Pharma blog, GlaxoSmithKline, Lundbeck, Menarini, Nycomed, Pfizer, Servier, Teva, app, iphone

The ranks of pharma iPhone apps are increasing all the time and recent months have seen new additions from Teva, …

News

Two $1 billion dollar acquisition deals go through

August 11, 2010
Sales and Marketing Alcon, M&A, MA, Novartis, Ratiopharm, Teva

Two major acquisition deals mounted by Teva and Novartis are in their final stages as they move to complete potentially …

News

Teva will invest $56m in Canadian plant

June 7, 2010
Manufacturing and Production Canada, Teva, production

Israeli generic drugmaker Teva Pharmaceutical Industries is planning to spend $54 million to expand a Canadian production plant for solid …

News

Teva staff in Ireland vote for industrial action

June 3, 2010
Manufacturing and Production Ireland, Teva

Workers at a plant operated by Teva in Ireland have voted to take industrial action in a dispute over redundancy …

News

Teva reports strong Q1 results

May 10, 2010
Sales and Marketing 2010 financials, Teva

Generics firm Teva Pharmaceuticals has reported strong first quarter results, driven by its patented multiple sclerosis therapy Copaxone. Sales of …

News

FDA warns Teva over California plant

April 30, 2010
Manufacturing and Production Teva, manufacturing compliance

Teva has become the latest drugmaker to be rebuked by the FDA for not responding effectively enough to compliance problems …

News
Cozaar

Merck to be hit by Cozaar generics

April 9, 2010
Merck, Teva, generics

Generic versions of Merck’s hypertension treatments Cozaar and Hyzaar are to be launched in the US for the first time. …

News

Teva to buy Ratiopharm for €3.6 billion

March 18, 2010
Sales and Marketing Ratiopharm, Teva

Teva has secured the acquisition of German generics business Ratiopharm with a last minute bid of 3.62 billion euros. Teva …

News
Ratiopharm HQ

Pfizer muscles in on Ratiopharm sale

March 11, 2010
Sales and Marketing Pfizer, Ratiopharm, Teva, generics

Pfizer has reportedly bid $4 billion for German generics firm Ratiopharm in a bid to rapidly expands its portfolio in …

News

Teva appoints Dr Phillip Frost chairman

March 11, 2010
Sales and Marketing Teva, appointment, sales and marketing

Teva Pharmaceutical Industries has appointed Dr Phillip Frost as chairman of the board of directors. His appointment is part of …

Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026